Welcome to the Potelligent® Technology Knowledge Center. The Potelligent® CHOK1SV cell line combines the advantages of Lonza's GS™ Expression System and CHOK1SV cell line with BioWa's engineered glycosylation technology. Highly productive and stable recombinant cell lines can be created rapidly and moved through to cGMP production seamlessly to generate antibodies with enhanced antibody dependent cellular cytotoxicity (ADCC). We are dedicated to sharing our findings with other technical communities in order to advance therapeutic development. Learn more about Lonza's Potelligent® CHOK1SV Technology in the below tab. To discover information regarding other areas of interest to you, visit the Lonza Knowledge Center.
To reach our Potelligent® Technology experts, email your contact information and questions to GSLonza@lonza.com.
- Brochures, Posters, and Presentations